These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 28524460)

  • 1. Commentary: Important design features to consider in observational research on the long-term outcomes of ADHD - reflections on Sibley et al. (2017) and Swanson et al. (2017).
    Larsson H
    J Child Psychol Psychiatry; 2017 Jun; 58(6):679-681. PubMed ID: 28524460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Editorial: The continuing contributions of multimodal treatment of attention over nearly two decades to initial attention-deficit hyperactivity disorder pharmacotherapy and long-term clinical course.
    Bloch MH
    J Child Psychol Psychiatry; 2017 Jun; 58(6):637-639. PubMed ID: 28524461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interventions in ADHD: A comparative review of stimulant medications and behavioral therapies.
    Rajeh A; Amanullah S; Shivakumar K; Cole J
    Asian J Psychiatr; 2017 Feb; 25():131-135. PubMed ID: 28262134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
    Foy JM; Earls MF
    Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response to commentary on the multimodal treatment study of ADHD (MTA): mining the meaning of the MTA.
    Swanson JM; Arnold LE; Vitiello B; Abikoff HB; Wells KC; Pelham WE; March JS; Hinshaw SP; Hoza B; Epstein JN; Elliott GR; Greenhill LL; Hechtman L; Jensen PS; Kraemer HC; Kotkin R; Molina B; Newcorn JH; Owens EB; Severe J; Hoagwood K; Simpson S; Wigal T; Hanley T;
    J Abnorm Child Psychol; 2002 Aug; 30(4):327-32. PubMed ID: 12108764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizes.
    Faraone SV; Glatt SJ
    J Clin Psychiatry; 2010 Jun; 71(6):754-63. PubMed ID: 20051220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parent-Reported Improvements in Family Functioning in a Randomized Controlled Trial of Lisdexamfetamine for Treatment of Parental Attention-Deficit/Hyperactivity Disorder.
    Babinski DE; Waxmonsky JG; Waschbusch DA; Humphery H; Pelham WE
    J Child Adolesc Psychopharmacol; 2017 Apr; 27(3):250-257. PubMed ID: 27991835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multimodal treatment in children and adolescents with attention-deficit/hyperactivity disorder: a 6-month follow-up.
    Duric NS; Assmus J; Gundersen D; Duric Golos A; Elgen IB
    Nord J Psychiatry; 2017 Jul; 71(5):386-394. PubMed ID: 28345387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy and safety profile of lisdexamfetamine dimesylate, a prodrug of d-amphetamine, for the treatment of attention-deficit/hyperactivity disorder in children and adults.
    Najib J
    Clin Ther; 2009 Jan; 31(1):142-76. PubMed ID: 19243715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medication therapy for attention deficit/hyperactivity disorder is associated with lower risk of fracture: a retrospective cohort study.
    Perry BA; Archer KR; Song Y; Ma Y; Green JK; Elefteriou F; Dahir KM
    Osteoporos Int; 2016 Jul; 27(7):2223-2227. PubMed ID: 26928186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulant effects in attention deficit hyperactivity disorder: theoretical and empirical issues.
    Denney CB
    J Clin Child Psychol; 2001 Mar; 30(1):98-109. PubMed ID: 11294083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Informed consent and stimulant medication: adolescents' and parents' ability to understand information about benefits and risks of stimulant medication for the treatment of attention-deficit/hyperactivity disorder.
    Schachter D; Tharmalingam S; Kleinman I
    J Child Adolesc Psychopharmacol; 2011 Apr; 21(2):139-48. PubMed ID: 21504355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term use of stimulants in children with attention deficit hyperactivity disorder: safety, efficacy, and long-term outcome.
    Hechtman L; Greenfield B
    Paediatr Drugs; 2003; 5(12):787-94. PubMed ID: 14658920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ADHD medication use, adherence, persistence and cost among Texas Medicaid children.
    Barner JC; Khoza S; Oladapo A
    Curr Med Res Opin; 2011; 27 Suppl 2():13-22. PubMed ID: 21973228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Household Diversion of Prescription Stimulants: Medication Misuse by Parents of Children with Attention-Deficit/Hyperactivity Disorder.
    Pham T; Milanaik R; Kaplan A; Papaioannou H; Adesman A
    J Child Adolesc Psychopharmacol; 2017 Oct; 27(8):741-746. PubMed ID: 28686059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term efficacy and safety of treatment with stimulants and atomoxetine in adult ADHD: a review of controlled and naturalistic studies.
    Fredriksen M; Halmøy A; Faraone SV; Haavik J
    Eur Neuropsychopharmacol; 2013 Jun; 23(6):508-27. PubMed ID: 22917983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post Hoc Analysis of Potential Predictors of Response to Atomoxetine for the Treatment of Adults with Attention-Deficit/Hyperactivity Disorder using an Integrated Database.
    Bushe C; Sobanski E; Coghill D; Berggren L; De Bruyckere K; Leppämäki S
    CNS Drugs; 2016 Apr; 30(4):317-34. PubMed ID: 27055440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is adjunctive pharmacotherapy in attention-deficit/hyperactivity disorder cost-effective in Canada: a cost-effectiveness assessment of guanfacine extended-release as an adjunctive therapy to a long-acting stimulant for the treatment of ADHD.
    Lachaine J; Sikirica V; Mathurin K
    BMC Psychiatry; 2016 Jan; 16():11. PubMed ID: 26774811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of one-year pharmacological treatment of adult attention-deficit/hyperactivity disorder (ADHD): an open-label prospective study of time in treatment, dose, side-effects and comorbidity.
    Fredriksen M; Dahl AA; Martinsen EW; Klungsøyr O; Haavik J; Peleikis DE
    Eur Neuropsychopharmacol; 2014 Dec; 24(12):1873-84. PubMed ID: 25453480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pilot study of stimulant medication for adults with attention-deficit/hyperactivity disorder (ADHD) who are parents of adolescents with ADHD: the acute effects of stimulant medication on observed parent-adolescent interactions.
    Babinski DE; Waxmonsky JG; Waschbusch DA; Humphrey H; Alfonso A; Crum KI; Bernstein M; Slavec J; Augustus JN; Pelham WE
    J Child Adolesc Psychopharmacol; 2014 Dec; 24(10):582-5. PubMed ID: 25386742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.